Baicalin–Zinc Complex Alleviates Inflammatory Responses and Hormone Profiles by Microbiome in Deoxynivalenol Induced Piglets

Introduction

Deoxynivalenol (DON), originally known as vomitoxin, can cause vomiting, diarrhea, anorexia, neurological disorders, and immune dysfunction in humans and animals (1, 2). DON was reported to be the most common food-related mycotoxins all over the world (3–5). A study shows that DON was detected in 73 and 92% of wheat and corn in the USA (6). In another study in China, the detection rate of DON in corn was 93.2%, and the average concentration was 1,356.9 μg/kg (7). The DON detection rate in each region is shown as follows: East Asia (84.8%), Northern Europe (74.2%), Central America (70.0%), Central Europe (69.8%), North America (64.1%), South Africa (63.2%), Eastern Europe (59.9%), Southern Europe (52.9%), sub-Saharan Africa (49.5%), Middle East/North Africa Region (47.8%), Southeast Asia (42.5%), Oceania (34.5%), South America (26.9%), and South Asia (23.1%) (8). Pigs are very sensitive to the toxic effects of DON, and the long-term consumption of DON in pig can delay growth and reduce immune performance (9, 10). Therefore, repairing intestinal damage induced by DON is an important subject in the livestock production.

At low DON concentrations, DON promotes the production of immune factors, thereby increasing the risk of chronic immune disease or infection susceptibility (11, 12). DON induces secretion of serum immunoglobulin M (IgM), immunoglobulin A (IgA), immunoglobulin E (IgE), and immunoglobulin G (IgG) in mice or farm animals (13–15). DON induces a significant increase in tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), interleukin-1α (IL-1α), interleukin-1β (IL-1β), and gene expression in porcine intestinal epithelial cells (IPEC-1 cell line) (16). Furthermore, some studies also showed that DON can interfere with immune response by altering intestinal microbiome balance (17, 18). Previous studies reported that the growth retardation induced by DON is associated with the secretion of satiety hormones, such as peptide YY (PYY), cholecystokinin (CCK), and 5-hydroxytryptamine (5-HT), and growth hormone (GH) (19, 20). Therefore, we intend to develop a feed additive to reduce the toxic effects of DON. Baicalin–zinc complex (BZN) is a complex of baicalin and zinc. Although there are few studies on BZN at present, it has been proved to have good anti-inflammatory and antioxidant properties, which suggest that it may relieve the toxic effects of DON in pigs (21, 22). Moreover, zinc is an essential trace element for animals. It is involved in a multitude of body functions, ranging from the metabolism of nutrients to bone development, and as an activator to mediate the immune function of pigs (23, 24). It is generally added at 2,000 mg/kg in swine production to reduce diarrhea and promote pig growth. Baicalin (5,6-dihydroxy-2-phenyl-4H-1-benzopyran-4-one-7-O-D-β-glucuronic acid) is an extract from Scutellaria baicalensis Georgi and Oroxylum indicum (L.) Kurz, and it is commonly used in the cure of gastrointestinal infections and inflammatory diseases (25, 26). The dietary baicalin supplementation is tightly correlated to the intestinal microbiota composition, and it was also reported that baicalin has good antioxidant and anti-inflammatory in some studies (26–28).

This study aimed to investigate the beneficial effect of BZN on intestinal microbiome, inflammatory responses, and hormone profiles in DON-challenged piglets and the association between intestinal microbiome and host immunity and hormone secretion.

Materials and Methods

DON-Contaminated Diet and BZN Synthesis

Basal diet inoculate with Fusarium graminearum R6576 was fermented for 14 days to form DON-contaminated diet as described by Wu et al. (29). F. graminearum R6576 was supplied by Huazhong Agricultural University and preserved by Institute of Subtropical Sciences, Chinese Academy of Sciences (30). Baicalin was fully dissolved in 1% sodium bicarbonate solution, then equal molar ratio zinc sulfate was added to baicalin solution. After completion of the reaction, the precipitation was BZN. The dose of BZN and DON was referred to the previous literature (31).

Animals, Diets, and Experimental Design

Forty weaned piglets with an average weight of 6.13 ± 0.42 kg (Landrace × Yorkshire, 21 days of age) were individually housed in a single column at the New wellful pig farm (New Wellful Co., Ltd, Hunan, China). Piglets were randomly divided into four diets, and 10 pigs were fed to each diet. The four groups were as follows: (1) control (Con) group (basal diet); (2) DON group (4 mg DON/kg basal diet); (3) BZN group (0.5% BZN basal diet); and (4) DBZN group (4 mg DON/kg and 0.5% BZN basal diet). The composition and nutrient level of the basal diet in this experiment is shown in Supplementary Table 1, and it meets nutrient requirements of pigs according to National Research Committee (NRC) (32, 33). All pigs were acclimated to the room for 3 days before the experiment, and experimental diets were provided in four equal daily meals at 7:30, 11:00, 14:30, and 18:00 for 14 days. Piglets housed on a 12-h light-dark cycle with free access to water, and the barn temperature was maintained at 30°C. Randomly selected seven pigs from each group for sampling after slaughter. After blood was collected by blood vessel, it was placed at room temperature for 1 h and centrifuged at 3,000 R for 15 min. The pale yellow liquid obtained was the serum. The intestine was opened in the middle ileum, and an appropriate amount of chyme was collected in a 50-ml sterile centrifugal tube. The collected serum and ileal chyme samples were quickly stored in liquid nitrogen. Serum and ileum chymes were stored at −80°C. The experiment was carried out under the supervision of the experimental animal ethics committee of the Institute of Subtropical Agriculture (Changsha, Human Province, China) (29, 34).

16s rRNA Sequencing

The 16s rRNA analysis of ileal chyme was conducted by Novogene Co., Ltd (Beijing, China) (35). The total DNA from ileal chyme was extracted by the CTAB/SDS method, and the DNA concentration and quality met the experimental requirements. Then, diluted the DNA to 1 mg/ml with sterile water. PCR was performed with specific primers as forward primer: ACTCCTACGGGAGGCAGCAG and reverse primer: GGACTACHVGGGTWTC TAAT (amplification of 16srRNA gene V3–V4 region); the PCR amplification products were detected and purified using a 2% agarose gel, then purified amplicons were used for the sequencing library. After the library has passed the quality assessment, it was sequenced on Ion S5TMXL (Thermo Fisher Scientific Co., Ltd., Waltham, CA, USA).

Bioinformatics Analysis

Raw reads were demultiplexed and quality-filtered as previously described (36). Operational taxonomic units (OTUs) were clustered with 97% similarity for the effective tags of all samples by using the UPARSE software (version 7.0.1001), then used the Mothur method (https://www.mothur.org/) and SILVA database to annotate the species at the level phylum, order, family, genus, and class. The R software (version 2.15.3) was used to draw principal component analysis (PCA) chart, principal co-ordinates analysis (PCoA) chart and heatmap. Alpha diversity was used to analyze the diversity of intestinal microbiome. Linear discriminant analysis effect size (LEfSe) analysis was used galaxy module [linear discriminant analysis (LDA) score >2.5].

Serum Indices (Immunoglobulins, Cytokines, Biochemical Indices, and Hormones Profiles)

Serum immunoglobulins: IgM, IgG, IgA, cytokines: TNF-α, IL-2, IFN-γ, IL-6, IL-1β, and hormones: 5-HT, GH, PYY, LEP, somatostatin (SST), insulin (INS), neuropeptide Y (NPY), insulin-like growth factor-1 (IGF-1), proopiomelanocortin (PMOC), agouti-related protein (AGRP), and glucagon-like peptide 1 (GLP-1) were determined using the commercially available ELISA kits from Nanjing Jiancheng Co., Ltd. (Jiangsu, China) (37).

The CX-4 automatic biochemical analyzer (Beckman Coulter, Brea, CA, USA) was used to measure the total cholesterol (CHOL), albumin (ALB), glucose (GLU), and blood urea nitrogen (BUN) in serum (38).

Real-Time Quantitative PCR

The total RNA was extracted from the hypothalamus and pituitary using the TRIzol Reagent (Thermo Fisher Scientific Co., Ltd, CA, USA). Real-time quantitative PCR was performed with a Roche Light Cycler 480II system (Roche Co., Ltd, Basel, Switzerland). Primers (PREMIER Biosoft International, San Francisco, CA, USA) (Supplementary Table 1) were designed using the Primer 5.0 software and synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). The RNA extraction and real-time quantitative PCR were conducted strictly according to previous studies [RT-PCR procedure: step 1: predenaturation program (30 s at 95°C); step 2: PCR (5 s at 95°C for denaturation and 30 s at 60°C for extension); and step 3: dissociation program (5 s at 60°C)] (37, 39, 40). In addition, the relative expression of target genes was calculated by the formula 2^−(ΔΔCt) (41).

Statistical Analysis

In addition to sequencing data, serum indices and mRNA expression were analyzed by the SPSS software (version 20, IBM Corp., Armonk, NY, USA). We filled the missing values with the mean, and the data were logarithmically transformed while outliers existed. Dietary BZN, DON, and their interactions were analyzed using two-way ANOVA. If there was a significant difference, we performed the Bonferroni t-test. At the same time, the Duncan's test was used to analyze the significant difference, and the criterion for significance judgment was p < 0.05. The GraphPad Prism Software (Version 7; La Jolla, CA, USA) was used to draw the figures, and the column shows mean ± SEM (42–44).

Results

Intestinal Microbiome Composition of Piglets

To characterize the composition of bacterial communities in the ileum, we collected a total of 28 piglets' ileum chymes for 16s sequencing. After quality filtering, 20,694,594 reads that were clustered into 1,096 OTU remained. At the phylum level (Figure 1A), Firmicutes was the main phylum in the intestinal microbiota of piglets among the four groups, and the relative Firmicutes content in the DON group is much higher (95%). The LEfSe analysis revealed that the relative Bacteroidetes content in the DON group was noticeably lower than that in the DBZN group (LDA > 2.5) (Figure 1D). At the genus level (Figure 1B), over 43% of reads were identified as unidentified members of Clostridiales. The LEfSe analysis revealed that the relative abundance of Intestinibacter, Agathobacter, and Veillonella in the DBZN group was noticeably higher than that in the DON group (LDA > 2.5) (Figure 1D). At the species level, for the Con group, intestinal microbiota was mainly enriched in genera belonging to Bacteroides (Figure 1C). The BZN group was mainly enriched by Streptococcus, Clostridium bornimense, and Actinobacillus minor, and the DBZN group was mainly enriched by Lactobacillus, Streptococcus, and so on (Figure 1E). The LEfSe analysis showed that BZN markedly increased the relative abundance of Clostridium perfringens in basal diet, and BZN markedly increased the relative abundance of Streptococcus porcorum in DON-contaminated diet (LDA > 2.5) (Figure 1D).

FIGURE 1

Figure 1. Effects of BZN and DON on intestinal microbiome composition of piglet. (A) Intestinal microbiome composition at the phylum level. (B) Intestinal microbiome composition at the genus level. (C) The LEfSe analysis at different gut microbiota taxa between Con and BZN groups (LDA score >2.5). (D) The LEfSe analysis at different gut microbiota taxa between DON and DBZN groups (LDA score >2.5). (E) Heatmap showing significantly different species. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol; LDA, linear discriminant analysis.

Diversity Change of Intestinal Microbiome of the Piglet

To detect the changes of intestinal microbiota composition during the experiment period, we evaluated the alpha diversity of piglet gut microbiota. The alpha diversity was first calculated using ace, chao 1, PD whole tree, and observed species. All measurements revealed that the BZN supplementation increased evenness and richness of the ileum microbiota in DON-contaminated diet (p < 0.05) (Figures 2A–D).

FIGURE 2

Figure 2. Alpha and beta diversity change of gut microbiota. (A) Alpha diversity base on the ACE index. (B) Alpha diversity base on the Phylogenetic diversity (PD) whole-tree index. (C) Alpha diversity base on the observed species index. (D) Alpha diversity base on the chao 1 index. (E) Principal coordinate analysis (PCoA) based on the binary Jaccard indices. (F) PCoA based on the weighted UniFrac indices. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. *p < 0.05. BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol.

To further reveal the differences in intestinal microbiota composition among the four groups, we evaluated the beta diversity of piglet intestinal microbiota using the binary Jaccard indices and weighted UniFrac (Figures 2E,F). PCoA revealed that although there was no obvious segregation of the BZN group and Con group, the Con group, DON group, and DBZN group can be distinguished from each other. Moreover, analysis of molecular variance (AMOVA) indicated that the differences in the binary Jaccard index between the DON group and DBZN group are significant (p < 0.05).

Metabolic Functional Change of Intestinal Microbiome of the Piglet

The Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUST) analysis was used to predict the function of intestinal microbiota (Figure 3). The results indicated that 10 pathways, including ATP-binding cassette (ABC) transporters, translation proteins, general function prediction only, ribosome Biogenesis, porphyrin and chlorophyll metabolism, sporulation, chromosome, transcription machinery, and arginine and proline metabolism were enriched in the Con group. We also identified seven pathways, such as two component system, purine metabolism, aminoacyl tRNA biosynthesis, pyrimidine metabolism, DNA repair and recombination proteins, methane metabolism, and amino acid-related enzymes were predicted to be enriched in the DON group. Seven pathways, including secretion system, transcription factors, bacterial motility proteins, transporters, fructose and mannose metabolism, cysteine and methionine metabolism and peptidases, were predicted to be enriched in the BZN and DBZN groups.

FIGURE 3

Figure 3. BZN supplementation changed the metabolic functions of intestinal microbiome of piglet at KEGG level 3. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Serum Inflammatory Responses Correlation With the Intestinal Microbiome Abundance

Serum immunoglobulin and cytokines were significantly affected by either supplementation of BZN, DON, or interaction (Figure 4A). Compared with the Con group, the BZN group increased the level of IgA, IgG, IgM, IFN-γ, IL-6, IL-1β, and IL-2 in serum (p < 0.05). In the DON-challenged group, the dietary BZN supplementation decreased the level of IL-2 and IFN-γ in serum (p < 0.05). The concentration of CHOL in serum was significantly influenced by the interaction effect of DON and BZN (p < 0.05). Moreover, the dietary BZN supplementation significantly increased the serum concentration of BUN and GLU in serum (p < 0.05).

FIGURE 4

Figure 4. BZN- and DON-mediated inflammatory responses and correlations with intestinal microbiome. (A) Serum inflammatory indices. ^abDifferent letters mean significantly difference. (B) The Spearman correlations between the intestinal microbiome and serum inflammatory indices. *p < 0.05, **p < 0.01. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. IL-1β, interleukin-1β; IgG, immunoglobulin G; IFN-γ, interferon-gamma γ; IL-6, interleukin-6; IgA, immunoglobulin A; GLU, glucose; IgM, immunoglobulin M; CHOL, total cholesterol; IL-2, interleukin-2; TNF-α, tumor necrosis factor-α; ALB, albumin; BUN, blood urea nitrogen; BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol.

The Spearman's correlation analysis was used to calculate the relationship between inflammatory and intestinal microbiome abundance. Intestinal microbiota was significantly associated with some immunity indices (Figure 4B). Of these, the abundances of Bacterium AD3011, Phaseolus vulgaris, Bacteroides vulgatus, or Streptococcus suis was negatively correlated to IgG, IgM, and IL-1β, and the abundance of Anaerosalibacter bizertensis, Streptococcus ferus, Oceanobacillus indicireducens, Bacillus coagulans, Oceanobacillus caeni, or Streptococcus plurextorum was positively correlated to IL-2 and IFN-γ. Moreover, the abundance of Lactobacillus ruminis was negatively correlated to IL-2.

Hormone Secretion Correlation With the Intestinal Microbiome Abundance

As shown in Figure 5A, after 2 weeks of experimental treatments, the interaction effect of DON and BZN on GH-related hormones in serum was statistically significant (p < 0.01). As compared with the Con group, the concentration of INS and GH of the BZN group was increased (p < 0.05). However, the dietary BZN supplementation increased in the concentration of SS, and decreased the concentration of INS in DON-challenged group (p < 0.05). As revealed in Figure 5, the concentration of PYY, AGRP, LEP, GLP-1, and NPY in serum was significantly affected by either supplementation of BZN, DON, or interaction (p < 0.05).

FIGURE 5

Figure 5. BZN- and DON-mediated hormone secretion and correlations with gut microbiota. (A) The concentration of serum hormone. (B) The Spearman correlations between the gut microbiota and serum inflammatory makers. ^*p < 0.05, ^**p < 0.01. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. IGF1, insulin-like growth factor 1; NPY, neuropeptide Y; SST, somatostatin; INS, insulin; GH, growth hormone; 5-HT, 5-hydroxytryptamine; PYY, peptide YY; PMOC, proopiomelanocortin; AGRP, agouti-related protein; LEP, leptin, GLP1, glucagon-like peptide-1; BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol. ^a,bdifferent letters means significantly difference (P < 0.05).

The Spearman's correlation analysis was used to calculate the relationship between hormone secretion and bacterial genera abundance (Figure 5B). First, the abundance of Lactobacillus agilis were positively correlated to the AGRP concentration in serum. As the heatmap shows, the abundance of Neisseria dentiae, Mobilibacterium massiliense, Bacteroides ovatus, Pasteurella aerogenes, or Clostridium bornimense was negatively correlated to the INS, GH, PYY, and PMOC concentration in serum, and the abundance of Anaerosalibacter bizertensis, Streptococcus ferus, Oceanobacillus indicireducens, Lactobacillus agilis, Bacillus coagulans, Bacillus thermoamylovorans, Weissella thailandensis, Oceanobacillus caeni, Streptococcus plurextorum, or Rothia nasimurium was positively correlated to the IGF-1, INS, GH, LEP, AGRP, and NPY concentration in serum.

Relative mRNA Expression in Hypothalamus and Pituitary

As shown in Figure 6, among the 13 hormones or their receptor genes assayed in the hypothalamus, eight genes were affected by dietary DON, BZN, or their interaction. Specifically, dietary DON exerted a main effect on the mRNA relative levels of insulin receptor (INR), AKT, 5-hydroxytryptamine receptor (HTR)3A1, HTR3A2, HTR3B2, and cholecystokinin (CCK)-2R (p < 0.05). The BZN supplementation exerted the main effect on the mRNA levels of SST and HTR3B2 (p < 0.05), whereas there were no genes significantly influenced by an interaction between the DON supplementation and the BZN supplementation (p > 0.05). Among the 14 hormones or their receptor genes assayed in the pituitary, four genes were affected by dietary DON, BZN, or their interaction. Specifically, dietary DON exerted a main effect of NPY, and the mRNA expression of INR and AKT in the pituitary was affected by dietary BZN (p < 0.05). Notably, the mRNA levels of INR, GLP-2, and AKT in the pituitary were influenced by the interaction between the DON supplementation and the BZN supplementation (p < 0.05).

FIGURE 6

Figure 6. Effect of DON and BZN in mRNA levels of hormone genes in hypothalamus (A) and pituitary gland (B). Column was mean ± SEM (n = 7). Different letters mean significant differences. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. SST, somatostatin; INR, insulin receptor; CCK-2R, cholecystokinin B receptor; NPY, neuropeptide Y; AKT, AKT serine/threonine kinase 1; HTR3A1, 5-hydroxytryptamine receptor 3A 1; HTR3A2, 5-hydroxytryptamine receptor 3A 2; HTR3B2, 5-hydroxytryptamine receptor 3B; COX-2, cyclooxygenase-2; CCK-1R, cholecystokinin type A receptor; GLP-2, glucagon-like peptide 2; BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol. ^a,bdifferent letters means significantly difference (P < 0.05).

Discussion

Deoxynivalenol is the most common mycotoxin in grains and its products, and it can cause growth retardation, anorexia, and immune abnormalities. In addition, DON also changes the composition of intestinal microbiota, and intestinal microbiota is closely associated with growth and immunity (17, 45). This study showed the impact of BZN supplementation on the intestinal microbiome composition, inflammatory, and hormone secretion in DON-challenged piglets.

Intestinal microbiota is the primary target of DON in animals. Dietary ingestion of DON impaired intestinal homeostasis and changed the composition of intestinal microbiome in mice, especially, DON reduced the abundance of Streptococcus (46, 47). Moreover, baicalin regulates intestinal microbiota homeostasis and participates in liver–gut axis interaction (48, 49). Our study showed that dietary BZN in DON-contaminated diet increased intestinal microbial richness and diversity of piglets. Increased intestinal microbial diversity indicates a better resistance to stress. This is similar to the argument that baicalin can reverse intestinal microbiota dysfunction in rats. Moreover, our results showed that there was a significant difference in beta diversity between DON and DBZN groups, which means that dietary BZN in DON-contaminated diets changed the intestinal microbiota structure of piglet. Heatmaps showed that Lactobacillus ruminis and Lactobacillus agilis were enriched in the DBZN group, and they were able to inhibit Escherichia coli, which means BZN may treat intestinal pathogen infection (50, 51). PICRUST showed that the dietary BZN supplementation in DON-contaminated diet enriched peptidases pathway and dietary BZN supplementation in basal diet-enriched secretion system and bacterial mobility protein pathway. In conclusion, the dietary BZN supplementation in DON-contaminated diet relieved the imbalance of the intestinal microbiome caused by DON.

Deoxynivalenol also induced the activation of nuclear factor kappa B (NF-κB) and trigger an inflammatory response, thus selectively inducing the expression of some genes, includes a series of cytokines, chemokines, and other inflammatory factors (17, 52). Studies have also shown that with a high dose of DON, the total serum IgA, IgG, and IgM levels are significantly different from those in the Con group (13, 53). Studies have shown that baicalin treatment can reduce the serum inflammatory biomarkers of spontaneously hypertensive rats, such as IL-6, IL-1β, and high-sensitivity C-reactive protein (hs-CRP). In addition, baicalin treatment can also significantly reduce the expression of toll-like receptor 2 (TLR2), IL-1β, TNF-α, and interleukin-23 (IL-23) in the colon in Spontaneously Hypertensive Rats (SHRs) (54). Baicalin can significantly reduce the serum interleukin-17 (IL-17), IL-6, and IL-1β expression in Ulcerative Colitis (UC) rats (55). In addition, it can also reduce the expression of CD14 and IL-6 in colonic mucosa and alleviate the severity of ulcers (56). The results of these studies have shown that baicalin treatment can inhibit the inflammatory symptoms of the intestinal tract. Our research found that DON and BZN and their interaction groups can make the expression levels of IL-2, IL-6, IgG, IgA, IgM, and IFN-γ significantly different from those of the Con group. Among them, BZN reduced the expression of IL-2 and IFN-γ caused by DON, which was in accordance with the results of a previous study (52). We also observed that the dietary BZN supplementation increased the serum IL-2, IFN-γ, and INS concentration in normal piglets. These results indicate that the effects of DON in normal piglets and DON-induced piglets are different. According to the Spearman correlation analysis, the concentration of IL-2 and IFN-γ was correlated to the abundance of Anaerosalibacter bizertensis, Streptococcus ferus, Oceanobacillus indicireducens, Bacillus coagulans, Oceanobacillus caeni, Lactobacillus ruminis, or Streptococcus plurextorum.

Previous literature studies have shown that the growth retardation and anorexia caused by DON may be related to the regulation of hormone secretion, such as 5-HT, GH, and IGF1 (19, 57, 58). Our experiment showed that the dietary BZN supplementation in DON-contaminated diets significantly increased the SS concentration in serum and significantly decreased the INS concentration in serum. SST is a kind of tetrapeptide that can inhibit the secretion of GH and control the secretion of pituitary hormone. It is assumed that the increase of somatostatin concentration will cause growth inhibition. However, it was also noted that the addition of DON and BZN could increase the secretion of GH. Therefore, we conclude that DON unbalanced the growth axis hormone secretion, and the supplementation of BZN can rebalance growth axis hormone secretion induced by DON. Notably, the concentration of GH was positively related to the abundance of Bacillus coagulans, Oceanobacillus indicireducens, Streptococcus plurextorum, and Rothia nasimurium and was negatively related to the abundance of Clostridium bornimense and Neisseria dentiae.

Conclusion

Taken together, these data suggested that BZN was correlated to the change in intestinal microbiota composition and modulated inflammatory and hormone secretion in piglet after the DON exposure. Moreover, the regulation of BZN on inflammation and hormone secretion was related to the change of the abundance of intestinal microbiota.

Data Availability Statement

The dataset can be found in NCBI (SRA data: PRJNA705396).

Ethics Statement

The animal study was reviewed and approved by The experiment was carried out under the supervision of the experimental Animal Ethics Committee of the institute of subtropical agriculture (Changsha, Human Province, China).

Author Contributions

AZ involved in writing—original draft, supervision, visualization, formal analysis, and project administration. PL contributed to methodology, funding acquisition, and project administration. ZC involved in investigation, conceptualization, and formal analysis. SL and MQ contributed to methodology and software. RT analyzed data curation. BT collected resources. All authors contributed to the article and approved the submitted version.

Funding

This research was supported by Special Funds for Construction of Innovative Provinces in Hunan Province (2019RS3022) and the Joints Funds of the National Science Foundation of China (Grant No: U20A2054).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2021.738281/full#supplementary-material

Abbreviations

5-HT, 5-hydroxytryptamine; HTR3A1, 5-hydroxytryptamine receptor 3A 1; HTR3A2, 5-hydroxytryptamine receptor 3A 2; HTR3B2, 5-hydroxytryptamine receptor 3B; AGRP, agouti-related protein; AKT, AKT serine/threonine kinase 1; ALB, albumin; BZN, baicalin–zinc complex; BUN, blood urea nitrogen; CCK, cholecystokinin; CCK-1R, cholecystokinin type A receptor; CCK-2R, cholecystokinin B receptor; CHOL, total cholesterol; COX-2, cyclooxygenase-2; DON, deoxynivalenol; GLP-1, glucagon-like peptide 1; GLP-2, glucagon-like peptide 2; GLU, glucose; GH, growth hormone; hs-CRP, high-sensitivity C-reactive protein; IgA, immunoglobulin A; IgE, immunoglobulin E; IgG, immunoglobulin G; IgM, immunoglobulin M; INS, insulin; INR, insulin receptor; IGF-1, insulin-like growth factor-1; IFN-γ, interferon-gamma; IL-1α, interleukin-1α; IL-1β, interleukin-1β; IL-2, interleukin-2; IL-6, interleukin-6; IL-8, interleukin-8; IL-17, interleukin-17; IL-23, interleukin-23; LEP, leptin; LDA, linear discriminant analysis; NPY, neuropeptide Y; NF-κB, nuclear factor kappa B; OTUs, operational taxonomic units; PYY, peptide YY; PCA, principal component analysis; PCoA, principal co-ordinates analysis; PMOC, proopiomelanocortin; SST, somatostatin; TLR-2, toll-like receptor 2; TNF-α, tumor necrosis factor-α.

References

1. Wang X, Chen X, Cao L, Zhu L, Zhang Y, Chu X, et al. Mechanism of deoxynivalenol-induced neurotoxicity in weaned piglets is linked to lipid peroxidation, dampened neurotransmitter levels, and interference with calcium signaling. Ecotoxicol Environ Saf. (2020) 194:110382. doi: 10.1016/j.ecoenv.2020.110382

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Yang C, Song G, Lim W. Effects of mycotoxin-contaminated feed on farm animals. J Hazard Mater. (2020) 389:122087. doi: 10.1016/j.jhazmat.2020.122087

PubMed Abstract | CrossRef Full Text | Google Scholar

3. World Health Organization. Evaluation of certain contaminants in food. World Health Organ Tech Rep Ser. (2017) 1002:1–166.

Google Scholar

4. Zhao L, Zhang L, Xu Z, Liu X, Chen L, Dai J, et al. Occurrence of Aflatoxin B(1), deoxynivalenol and zearalenone in feeds in China during 2018-2020. J Anim Sci Biotechnol. (2021) 12:74. doi: 10.1186/s40104-021-00603-0

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Ma R, Zhang L, Liu M, Su YT, Xie WM, Zhang NY, et al. Individual and combined occurrence of mycotoxins in feed ingredients and complete feeds in China. Toxins. (2018) 10:113. doi: 10.3390/toxins10030113

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Canady R, Coker R, Egan SK, Krska R, Olsen M, Resnik S, et al. T-2 and HT-2 in WHO/IPCS safety evaluation of certain mycotoxins in food. FAO Food Nutr Paper. (2001) 74:557–680.

Google Scholar

7. Guan S, Gong M, Yin Y, Huang R, Ruan Z, Zhou T, et al. Occurrence of mycotoxins in feeds and feed ingredients in China. J Food Agric Environ. (2011) 9:163–7. doi: 10.1016/j.ifset.2011.01.006

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Gruber-Dorninger C, Jenkins T, Schatzmayr G. Global mycotoxin occurrence in feed: a ten-year survey. Toxins. (2019) 11:375. doi: 10.3390/toxins11070375

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Eriksen GS, Pettersson H. Toxicological evaluation of trichothecenes in animal feed. Anim Feed Sci Technol. (2004) 114:205–39. doi: 10.1016/j.anifeedsci.2003.08.008

CrossRef Full Text | Google Scholar

10. Liu M, Zhang L, Chu XH, Ma R, Wang YW, Liu Q, et al. Effects of deoxynivalenol on the porcine growth performance and intestinal microbiota and potential remediation by a modified HSCAS binder. Food Chem Toxicol. (2020) 141:111373. doi: 10.1016/j.fct.2020.111373

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Payros D, Alassane-Kpembi I, Pierron A, Loiseau N, Pinton P, Oswald IP. Toxicology of deoxynivalenol and its acetylated and modified forms. Arch Toxicol. (2016) 90:2931–57. doi: 10.1007/s00204-016-1826-4

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Zhang L, Ma R, Zhu MX, Zhang NY, Liu XL, Wang YW, et al. Effect of deoxynivalenol on the porcine acquired immune response and potential remediation by a novel modified HSCAS adsorbent. Food Chem Toxicol. (2020) 138:111187. doi: 10.1016/j.fct.2020.111187

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Pestka JJ. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett. (2003) 140–1:287–95. doi: 10.1016/S0378-4274(03)00024-9

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Pestka JJ, Zhou H-R, Moon Y, Chung YJ. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett. (2004) 153:61–73. doi: 10.1016/j.toxlet.2004.04.023

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Grenier B, Loureiro-Bracarense A-P, Lucioli J, Pacheco GD, Cossalter A-M, Moll W-D, et al. Individual and combined effects of subclinical doses of deoxynivalenol and fumonisins in piglets. Mol Nutr Food Res. (2011) 55:761–71. doi: 10.1002/mnfr.201000402

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Cano PM, Seeboth J, Meurens F, Cognie J, Abrami R, Oswald IP, et al. Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response. PLoS ONE. (2013) 8:e53647. doi: 10.1371/journal.pone.0053647

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Liao Y, Peng Z, Chen L, Nüssler AK, Liu L, Yang W. Deoxynivalenol, gut microbiota and immunotoxicity: a potential approach? Food Chem Toxicol. (2018) 112:342–54. doi: 10.1016/j.fct.2018.01.013

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Sobrova P, Adam V, Vasatkova A, Beklova M, Zeman L, Kizek R. Deoxynivalenol and its toxicity. Interdiscip Toxicol. (2010) 3:94–9. doi: 10.2478/v10102-010-0019-x

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Flannery BM, Clark ES, Pestka JJ. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY. Toxicol Sci. (2012) 130:289–97. doi: 10.1093/toxsci/kfs255

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Amuzie CJ, Pestka JJ. Suppression of insulin-like growth factor acid-labile subunit expression–a novel mechanism for deoxynivalenol-induced growth retardation. Toxicol Sci. (2010) 113:412–21. doi: 10.1093/toxsci/kfp225

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Yang H, Lu Y, Zeng XF, Li L, Zhang RP, Ren ZK, et al. Antichronic gastric ulcer effect of zinc-baicalin complex on the acetic acid-induced chronic gastric ulcer rat model. Gastroenterol Res Pract. (2018) 2018:1275486. doi: 10.1155/2018/1275486

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Gao Z, Xu H, Chen X, Chen H. Antioxidant status and mineral contents in tissues of rutin and baicalin fed rats. Life Sci. (2003) 73:1599–607. doi: 10.1016/S0024-3205(03)00487-9

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Hill GM, Shannon MC. Copper and zinc nutritional issues for agricultural animal production. Biol Trace Elem Res. (2019) 188:148–59. doi: 10.1007/s12011-018-1578-5

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Hostetler CE, Kincaid RL, Mirando MA. The role of essential trace elements in embryonic and fetal development in livestock. Vet J. (2003) 166:125–39. doi: 10.1016/S1090-0233(02)00310-6

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Li C, Lin G, Zuo Z. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Disposit. (2011) 32:427–45. doi: 10.1002/bdd.771

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. (2017) 131:68–80. doi: 10.1016/j.ejmech.2017.03.004

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. Neuroprotective and cognitive enhancement potentials of baicalin: a review. Brain Sci. (2018) 8:104. doi: 10.3390/brainsci8060104

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Fang P, Yu M, Shi M, Bo P, Gu X, Zhang Z. Baicalin and its aglycone: a novel approach for treatment of metabolic disorders. Pharmacol Rep. (2020) 72:13–23. doi: 10.1007/s43440-019-00024-x

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Wu L, Liao P, He L, Feng Z, Ren W, Yin J, et al. Dietary L-arginine supplementation protects weanling pigs from deoxynivalenol-induced toxicity. Toxins. (2015) 7:1341–54. doi: 10.3390/toxins7041341

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Wu L, Wang W, Yao K, Zhou T, Yin J, Li T, et al. Effects of dietary arginine and glutamine on alleviating the impairment induced by deoxynivalenol stress and immune relevant cytokines in growing pigs. PLoS ONE. (2013) 8:e69502. doi: 10.1371/journal.pone.0069502

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Zha A, Cui Z, Qi M, Liao S, Chen L, Liao P, et al. Dietary baicalin zinc supplementation alleviates oxidative stress and enhances nutrition absorption in deoxynivalenol challenged pigs. Curr Drug Metab. (2020) 21:614–25. doi: 10.2174/1389200221666200302124102

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Council NR. Nutrient Requirements of Swine: Eleventh Revised Edition. Washington, DC: The National Academies Press (2012). p. 420.

Google Scholar

33. Zha A, Liao P, Tan B, Cui Z, Liao S, Chen L, et al. Dietary baicalin zinc supplementation alleviates oxidative stress and enhances nutrition absorption in deoxynivalenol challenged pigs. Curr Drug Metab. (2020) 10:614–25.

PubMed Abstract | Google Scholar

34. Chen S, Tan B, Xia YY, Liao SM, Wang MW, Yin J, et al. Effects of dietary gamma-aminobutyric acid supplementation on the intestinal functions in weaning piglets. Food Funct. (2019) 10:366–78. doi: 10.1039/C8FO02161A

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Zha A, Cui Z, Qi M, Liao S, Yin J, Tan B, et al. Baicalin-copper complex modulates gut microbiota, inflammatory responses, and hormone secretion in don-challenged piglets. Animals. (2020) 10:1535. doi: 10.3390/ani10091535

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Li Y, Wang X, Wang X-q, Wang J, Zhao J. Life-long dynamics of the swine gut microbiome and their implications in probiotics development and food safety. Gut Microbes. (2020) 11:1824–32. doi: 10.1080/19490976.2020.1773748

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Qi M, Tan B, Wang J, Liao S, Li J, Liu Y, et al. Post-natal growth retardation associated with impaired gut hormone profiles, immune and antioxidant function in pigs. Front Endocrinol. (2019) 10:660. doi: 10.3389/fendo.2019.00660

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Zhao Y, Wang J, Wang H, Huang Y, Qi M, Liao S, et al. Effects of gaba supplementation on intestinal SIgA secretion and gut microbiota in the healthy and ETEC-infected weanling piglets. Mediators Inflamm. (2020) 2020:7368483-. doi: 10.1155/2020/7368483

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Wang J, Zeng L, Tan B, Li G, Huang B, Xiong X, et al. Developmental changes in intercellular junctions and Kv channels in the intestine of piglets during the suckling and post-weaning periods. J Anim Sci Biotechnol. (2016) 7:4. doi: 10.1186/s40104-016-0063-2

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Duan Y, Zhong Y, Xiao H, Zheng C, Song B, Wang W, et al. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets. FASEB J. (2019) 33:10019–33. doi: 10.1096/fj.201900665RR

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Yan S, Zhu C, Yu T, Huang W, Huang J, Kong Q, et al. Studying the differences of bacterial metabolome and microbiome in the colon between landrace and meihua piglets. Front Microbiol. (2017) 8:1812. doi: 10.3389/fmicb.2017.01812

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Zhao L, Feng Y, Deng J, Zhang NY, Zhang WP, Liu XL, et al. Selenium deficiency aggravates aflatoxin B1-induced immunotoxicity in chick spleen by regulating 6 selenoprotein genes and redox/inflammation/apoptotic signaling. J Nutr. (2019) 149:894–901. doi: 10.1093/jn/nxz019

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Andrade VS, Rojas DB, de Andrade RB, Kim TDH, Vizuete AF, Zanatta Â, et al. A possible anti-inflammatory effect of proline in the brain cortex and cerebellum of rats. Mol Neurobiol. (2018) 55:4068–77. doi: 10.1007/s12035-017-0626-z

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Le T-H, Alassane-Kpembi I, Oswald IP, Pinton P. Analysis of the interactions between environmental and food contaminants, cadmium and deoxynivalenol, in different target organs. Sci Total Environ. (2018) 622–623:841–8. doi: 10.1016/j.scitotenv.2017.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Qi M, Tan B, Wang J, Liao S, Deng Y, Ji P, et al. The microbiota-gut-brain axis: a novel nutritional therapeutic target for growth retardation. Crit Rev Food Sci Nutr. (2021) 60:1–26. doi: 10.1080/10408398.2021.1879004

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Vignal C, Djouina M, Pichavant M, Caboche S, Waxin C, Beury D, et al. Chronic ingestion of deoxynivalenol at human dietary levels impairs intestinal homeostasis and gut microbiota in mice. Arch Toxicol. (2018) 92:2327–38. doi: 10.1007/s00204-018-2228-6

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Ali-Vehmas T, Rizzo A, Westermarck T, Atroshi F. Measurement of antibacterial activities of T-2 toxin, deoxynivalenol, ochratoxin A, aflatoxin B1 and fumonisin B1 using microtitration tray-based turbidimetric techniques. Zentralblatt fur Veterinarmedizin Reihe A. (1998) 45:453–8. doi: 10.1111/j.1439-0442.1998.tb00848.x

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Zhu L, Xu LZ, Zhao S, Shen ZF, Shen H, Zhan LB. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol. (2020) 104:5449–60. doi: 10.1007/s00253-020-10527-w

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Noh K, Kang Y, Nepal MR, Jeong KS, Oh DG, Kang MJ, et al. Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics. Molecules. (2016) 21:337. doi: 10.3390/molecules21030337

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Shi S, Cheng B, Gu B, Sheng T, Tu J, Shao Y, et al. Evaluation of the probiotic and functional potential of Lactobacillus agilis 32 isolated from pig manure. Lett Appl Microbiol. (2020) 73:9–19. doi: 10.1111/lam.13422

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Yu X, Åvall-Jääskeläinen S, Koort J, Lindholm A, Rintahaka J, von Ossowski I, et al. A comparative characterization of different host-sourced lactobacillus ruminis strains and their adhesive, inhibitory, and immunomodulating functions. Front Microbiol. (2017) 8:657. doi: 10.3389/fmicb.2017.00657

PubMed Abstract | CrossRef Full Text | Google Scholar

52. He K, Pan X, Zhou HR, Pestka JJ. Modulation of inflammatory gene expression by the ribotoxin deoxynivalenol involves coordinate regulation of the transcriptome and translatome. Toxicol Sci. (2013) 131:153–63. doi: 10.1093/toxsci/kfs266

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Goyarts T, Dänicke S, Tiemann U, Rothkötter HJ. Effect of the Fusarium toxin deoxynivalenol (DON) on IgA, IgM and IgG concentrations and proliferation of porcine blood lymphocytes. Toxicol In Vitro. (2006) 20:858–67. doi: 10.1016/j.tiv.2005.12.006

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Wu DD, Ding LQ, Tang XT, Wang WJ, Chen Y, Zhang T. baicalin protects against hypertension-associated intestinal barrier impairment in part through enhanced microbial production of short-chain fatty acids. Front Pharmacol. (2019) 10:13. doi: 10.3389/fphar.2019.01271

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Liang S, Deng X, Lei L, Zheng Y, Ai J, Chen LL, et al. The comparative study of the therapeutic effects and mechanism of baicalin, baicalein, and their combination on ulcerative colitis rat. Front Pharmacol. (2019) 10:15. doi: 10.3389/fphar.2019.01466

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Fu Y-J, Xu B, Huang S-W, Luo X, Deng X-L, Luo S, et al. Baicalin prevents LPS-induced activation of TLR4/NF-kappaB p65 pathway and inflammation in mice via inhibiting the expression of CD14. Acta Pharmacol Sin. (2020) 42:88–96. doi: 10.1038/s41401-020-0411-9

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Terciolo C, Maresca M, Pinton P, Oswald IP. Review article: role of satiety hormones in anorexia induction by Trichothecene mycotoxins. Food Chem Toxicol. (2018) 121:701–14. doi: 10.1016/j.fct.2018.09.034

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Bonnet MS, Roux J, Mounien L, Dallaporta M, Troadec JD. Advances in deoxynivalenol toxicity mechanisms: the brain as a target. Toxins. (2012) 4:1120–38. doi: 10.3390/toxins4111120

PubMed Abstract | CrossRef Full Text | Google Scholar